The effect of intramural and subserous uterine fibroids on implantation and clinical pregnancy rates in patients having intracytoplasmic sperm injection

被引：50

作者：

Yarali H. ^{[1
]}

Bukulmez O. ^{[1
]}

机构：

[1] Div. of Reproductive Endocrinology, Department of Obstetrics, Hacettepe Univ. School of Medicine, Gaziosmanpasa, Ankara 06780

来源：

Archives of Gynecology and Obstetrics | 2002年 / 266卷 / 1期

关键词：

Clinical pregnancy; Implantation; Intracytoplasmic sperm injection; Uterine fibroids;

D O I：

10.1007/PL00007491

中图分类号：

学科分类号：

摘要：

Our objective was to assess the effects of intramural and subserous fibroids on intracytoplasmic sperm injection (ICSI) in a retrospective case-control study of 108 women with uterine fibroids and 324 controls. The fibroids were located and measured by transvaginal ultrasound performed just before the ICSI cycle and all patients had normal endometrial scan. Seventy-three women had intramural and 35 women had subserous fibroids and the maximum diameter in any patient ranged from 0.5-10 cm. The number of fibroids in a patient ranged from 1-8. The first cycle outcome was compared with an age and body mass index matched 324 ICSI patients/cycles. All couples had male factor infertility. The ICSI cycles of patients with intramural and subserous fibroids were comparable in terms of the days of ovarian stimulation, the total dose of gonadotropin used, estradiol level on day of hCG administration, the number of metaphase II oocytes retrieved, fertilization and cleavage rates, number and quality of embryos developed and transferred. The implantation and clinical pregnancy rates were similar. We conclude that the presence of intramural and subserous fibroids does not adversely effect clinical pregnancy and implantation rates in patients undergoing ICSI.

引用

页码：30 / 33

页数：3

共 15 条

[1]

Bukulmez O., Yarali H., Yucel A., Sari T., Gurgan T., Intracytoplasmic sperm injection versus in vitro fertilization for patients with a tubal factor as their sole cause of infertility: A prospective, randomized trial, Fertil Steril, 73, pp. 38-42, (2000)

[2]

Buttram V.C. Jr., Reiter R.C., Uterine leiomyomata: Etiology, symptomatology, and management, Fertil Steril, 36, pp. 433-445, (1981)

[3]

Deligdish L., Loewenthal M., Endometrial changes associated with myomata of the uterus, J Clin Pathol, 23, pp. 676-680, (1970)

[4]

Eldar-Geva T., Meagher S., Healy D.L., MacLachlan V., Breheny S., Wood C., Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment, Fertil Steril, 70, pp. 687-691, (1998)

[5]

Farhi J., Ashkenazi J., Feldberg D., Dicker D., Orvieto R., Ben Rafael Z., Effect of uterine leiomyomata on the results of in-vitro fertilization treatment, Hum Reprod, 10, pp. 2576-2578, (1995)

[6]

Hunt J.E., Wallach E.E., Uterine factors in infertility - An overview, Clin Obstet Gynecol, 17, pp. 44-64, (1974)

[7]

Iosif C.S., Akerlund M., Fibromyomas and uterine activity, Acta Obstet Gynecol Scand, 62, pp. 165-167, (1983)

[8]

Jacobson F.N., Enzer N., Uterine myomas and endometrium, Obstet Gynecol, 7, pp. 206-210, (1956)

[9]

Kruger T.F., Menkveld R., Stander F.S., Lombard C.J., Van der Merwe J.P., Van Zyl J.A., Smith K., Sperm morphologic features as a prognostic factor in in vitro fertilization, Fertil Steril, 46, pp. 1118-1123, (1986)

[10]

Ramzy A.M., Sattar M., Amin Y., Mansour R.T., Serour G.I., Aboulghar M.A., Uterine myomata and outcome of assisted reproduction, Hum Reprod, 13, pp. 198-202, (1998)

← 1 2 →